Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 72 results:
Author Title [ Type] Year Filters: Keyword is Colorectal Neoplasms [Clear All Filters]
A 20-year single center experience in the surgical treatment of colorectal liver metastasis..
J BUON. 23(6), 1640-1647.
(2018). Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma..
Cancer Res. 62(23), 6820-2.
(2002). Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence..
Scand J Gastroenterol. 49(3), 381-2.
(2014). Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence..
Gut Liver. 11(5), 733-734.
(2017). Age-associated prognosis following curative resection for colorectal cancer..
Tech Coloproctol. 8 Suppl 1, s144-6.
(2004). AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas..
World J Gastroenterol. 16(20), 2476-83.
(2010). AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer..
Clin Colorectal Cancer. 17(4), e631-e637.
(2018). Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab..
Clin Colorectal Cancer. 18(4), e370-e384.
(2019). Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions..
Gastroenterology. 122(3), 606-13.
(2002). Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer..
Anticancer Res. 39(4), 2129-2138.
(2019). Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes..
BMC Cancer. 13, 49.
(2013). Brain metastases in colorectal cancer..
Tech Coloproctol. 14 Suppl 1, S67-8.
(2010). Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)..
Crit Rev Oncol Hematol. 76(1), 61-70.
(2010). Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer..
Tech Coloproctol. 8 Suppl 1, s187-9.
(2004). Colorectal cancer in patients over 70 years of age: determinants of outcome..
Tech Coloproctol. 8 Suppl 1, s112-5.
(2004). Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases..
PLoS One. 9(12), e114404.
(2014). The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer..
Tumour Biol. 35(6), 5993-6002.
(2014). The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases..
Clin Epigenetics. 9, 46.
(2017). Current treatment of colorectal liver metastases..
Tech Coloproctol. 8 Suppl 1, s174-6.
(2004). Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms..
World J Gastroenterol. 17(4), 444-8.
(2011). Discrepancies and misconceptions of perceived colorectal cancer screening barriers between primary health professionals and unscreened population. A comparative study in Greece..
J BUON. 23(7), 67-76.
(2018). Does emergency surgery affect resectability of colorectal cancer?.
Acta Chir Belg. 108(2), 219-25.
(2008). The effect of bevacizumab on colon anastomotic healing in rats..
Int J Colorectal Dis. 25(12), 1465-73.
(2010). Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis..
Lancet Oncol. 11(8), 753-62.
(2010). EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab..
J Cancer Res Clin Oncol. 140(5), 737-48.
(2014).